Insider Transactions Reported by 8 Insiders of Genprex, Inc.

Symbol
GNPX on Nasdaq
Location
Austin, TX

There are no Buy or Sell transactions made by insiders since 17 Jan 2025

Genprex, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rodney Varner Chairman, President and CEO, Director $1,245,464 18 Feb 2024
CATHERINE VACZY EVP GC Chief Strategy Officer $279,575 21 Apr 2023
Hermant Kumar Chief Mfgr & Tech Officer $211,000 18 Feb 2023
Ryan Confer President, CEO and CFO, Director $21,917 22 Dec 2025
Mark Berger Chief Medical Officer $13,852 22 Dec 2025
BRENT LONGNECKER Director $4,403 22 Dec 2025
Jose Antonio Moreno Toscano Director $4,395 22 Dec 2025
William R. Wilson Jr. Director $4,395 22 Dec 2025

Recent Insider Transactions by Companies or Individuals for Genprex, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.